Articles by Wiley

CS1002 plus CS1003 showed promising antitumor activity and had a manageable safety profile across a broad dosing range in trials

Findings support the use of immune checkpoint blockers as standard therapies in advanced skin cancer

The method could also distinguish between patients with early versus later stages of OSCC

Some populations have improved representation in cancer clinical trials while others remain under-represented

The relationship between cognitive decline, bone loss, and fracture risk may be driven by shared risk factors

New protein markers may indicate which patients have stable forms of CLL and which have more aggressive types

Study examines the key differences between severe inflammation in COVID-19 vs cytokine storm

A systematic review has found that most commercial COVID-19 tests do not meet WHO standards

According to a new analysis, the rate of new diagnosed cases increased 5.5 percent from 1990 to 2017

New review shows that antibody tests could have a useful role in detecting if someone has had COVID-19, but that timing is important

In a recent study, several of the markers correlated strongly with known heart failure markers and also predicted which patients were most likely to die prematurely

Recently published review finds that not only are MMR, MMRV, and MMR+V vaccines effective, they do not increase the risk of autism

A new study provides important insights on the potential origins of the most recent outbreak of viral pneumonia in China, which started in the middle of December

Clinical relevance of genome-wide polygenic score may be less than claimed